[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595731":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":24,"locations":24,"responsibleParty":29,"collaborators":24,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":24,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":24,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":56,"whyStopped":24,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":24},{"fullName":5,"class":6},"University of Nove de Julho","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental Group (EG)","EXPERIMENTAL","This group will receive treatment with oculomotor therapy",[13],"Other: Oculomotor therapy",{"label":15,"type":6,"description":16,"interventionNames":17},"Control group (CG)","This group will not receive any type of treatment",[18],"Other: No Treatment Added",[20,25],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Oculomotor therapy","Oculomotor therapy will follow and adapt the protocol for treating convergence insufficiency (CI). Procedures will be organized progressively, from easiest to most difficult. Gross convergence techniques: (1) Brock String: A 1.5-2 m cord with colored beads; the patient focuses on each bead to train binocular fusion, observing the \"X\" shape of the cord. (2) Barillé Chart: A card with paired images for each eye; the patient merges the images into one using convergence and sensory fusion. Accommodative techniques: (1) Eccentric Circles: Printed circles with eccentric marks; viewed through filters to train motor and sensory fusion by aligning them into a single 3D image. (2) Opaque Lifesaver Cards: Cards with figures on an opaque background, used with red-green filters to stimulate convergence and fixation by reducing peripheral stimuli and enhancing visual attention.",[9],null,{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":24},"No Treatment Added","Participants in the control group will not receive any type of treatment for a period of five weeks. After this period, they will be re-evaluated",[15],{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Fabiano Politti","Principal Investigator","100595731","effect-of-oculomotor-therapy-in-individuals-with-convergence-insufficiency-100595731",false,"NCT07036263","Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency","\"Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency: A Blind Randomized Clinical Trial\"","Inclusion Criteria:\n\n* Individuals diagnosed with convergence insufficiency (CI);\n* Aged between 18 and 60 years;\n* Physically active individuals;\n* Without cognitive impairments;\n* Without vestibular system impairments (e.g., dizziness).\n\nExclusion Criteria:\n\n* Diagnosis of neurodegenerative diseases (e.g., Parkinson's, ALS);\n* Presence of dementia;\n* History of stroke;\n* Presence of vestibular disorders;\n* Systemic neuromuscular diseases;\n* Disabling musculoskeletal pain;\n* Diagnosis of diabetic polyneuropathy;\n* Use of joint prostheses;\n* Ongoing physical therapy treatment;\n* Lack of physical ability to perform the prescribed physical activities.","ALL","18 Years","60 Years",{"count":44,"type":45},70,"ESTIMATED","INTERVENTIONAL",[48],"NA","The aim of this study is to investigate the effect of oculomotor therapy in individuals with ocular convergence insufficiency.",[51],"Convergence Insufficiency",[53,54,55],"Convergence insufficiency","Postural control","Clinical trial","NOT_YET_RECRUITING","2025-06-23",{"date":59,"type":60},"2025-06-25","ACTUAL",{"date":62,"type":45},"2025-08-01",{"date":64,"type":45},"2025-12-30",{"name":5,"class":6}]